LG Chem, Ltd., a global chemical company, announced that it has completed its previously announced acquisition of AVEO Oncology (AVEO), a commercial stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer, in an all-cash transaction with an implied equity value of $571M on a fully diluted basis.…